AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law)—why? One of the ballooning costs are clinical trials. Pharma/biotech often outsource their trials to CROs (contract research organisations). But many CROs are incentivised to make trials as bloated and inefficient as possible. That means more money and less results. Meri Beckwith is building the anti-CRO: Lindus Health—to solve this problem.
0:00 Intro
1:39 The big problem in drug discovery
4:10 Why do CROs exist?
7:24 The incentive problem in drug discovery/CROs
10:57 Pharma are anti-startups
12:11 How much a clinical trial costs
15:11 How can you compete with big CROs?
17:26 Are you going to build your own drug pipeline?
18:56 Lessons from VC to Founder
23:42 Brand/PR/Positioning as a biotech startup
29:03 Billion dollar ideas in bio/health
31:33 Habits that have helped Meri
Links
Lindus Health: https://www.lindushealth.com/
Meri Beckwith: https://twitter.com/meribeckwith
Mithi Thaya: https://www.linkedin.com/in/mithi-thaya/
Dr Mustafa Sultan: https://www.musty.io/